Dry Plant Extract Production via Segmented Solvent Extraction

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for producing dry plant extracts, such as Sinupret, face challenges in maintaining consistent quality and efficacy due to limitations in extraction and drying processes, which affect the pharmacological effectiveness of phytopharmaceuticals used for treating inflammatory and infectious diseases of the upper airways.

Innovation Solution

A twofold extraction process involving an initial aqueous/ethanolic extraction followed by a second aqueous extraction, with subsequent drying under controlled conditions, enhances the enrichment of active ingredients in the dry plant extract, resulting in improved pharmacological efficacy and dosing efficiency.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If a single aqueous/ethanolic extraction is used, then the extraction process is simple and quick, but the enrichment of active ingredients is insufficient

Engineering Contradiction:
Improveextraction speedVSAvoidactive ingredient concentration
Core Design Contradiction:
ProductivityVSQuantity of substance

Solution Approach 1:

The extraction process is divided into two sequential steps: a first aqueous/ethanolic extraction followed by a second aqueous extraction. This segmentation allows different solvents to target different active ingredients, with the first extraction capturing ethanol-soluble compounds and the second extraction capturing water-soluble compounds, thereby achieving comprehensive enrichment of active ingredients while maintaining reasonable extraction speed

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The extraction process utilizes parameter changes by switching between different solvent systems (aqueous/ethanolic mixture followed by pure aqueous solution). This change in extraction parameters enables selective dissolution of different active ingredient classes, optimizing both the speed and completeness of extraction without requiring excessive time

Inventive Principle:
Principle #35Parameter changes

2Ease of manufacture

If conventional drying methods are used, then the drying process is simple, but the quality consistency and pharmacological effectiveness are compromised

Engineering Contradiction:
Improvedrying process simplicityVSAvoidquality consistency
Core Design Contradiction:
Ease of manufactureVSReliability

Solution Approach 1:

The drying process employs controlled parameter changes including temperature modulation and vacuum conditions. By adjusting these parameters during the drying phase, the method maintains the pharmacological activity of active ingredients while achieving consistent dry extract quality, resolving the contradiction between manufacturing simplicity and quality reliability

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent replaces conventional mechanical drying systems with a controlled thermal and vacuum drying system. This substitution allows for gentler, more controlled water removal that preserves the chemical integrity and pharmacological properties of the extract, thereby improving quality consistency without significantly complicating the manufacturing process

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

3Quantity of substance

If a twofold extraction process is implemented, then the enrichment of active ingredients is improved, but the process complexity increases

Engineering Contradiction:
Improveactive ingredient concentrationVSAvoidextraction process complexity
Core Design Contradiction:
Quantity of substanceVSDevice complexity

Solution Approach 1:

The extraction process is segmented into two distinct but complementary steps using different solvent systems. The first aqueous/ethanolic extraction targets specific active ingredients while the second aqueous extraction captures others, achieving comprehensive enrichment. This segmentation is implemented in a way that maintains process manageability by using straightforward sequential operations rather than complex parallel systems

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The two-extraction system achieves multi-functionality by using different solvent compositions to target different classes of active ingredients. The aqueous/ethanolic mixture handles ethanol-soluble compounds while the pure aqueous solution handles water-soluble compounds, making the overall process universally effective for extracting diverse active ingredients from the plant material without requiring multiple separate processing lines

Inventive Principle:
Principle #6Universality (Multi-functionality)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The improved dry plant extract demonstrates enhanced antimicrobial, anti-inflammatory, and expectorant effects, effectively treating sinusitis and rhinosinusitis by inhibiting pathogens and viruses, and promoting mucociliary clearance without synthetic-chemical components.

Implementation Method 1

alcoholic/aqueous extraction of Rumicis herba, Verbena officinalis, Sambucus nigra, Primula veris and Gentiana lutea

Methodology Applied
Scientific EffectSolvation: Solvation

Implementation Method 2

aqueous/ethanolic extraction

Methodology Applied
Scientific EffectLiquid-Liquid Extraction: Liquid-Liquid Extraction

Implementation Method 3

drying of the supernatants and provision of the dry plant extract

Methodology Applied
Scientific EffectEvaporation: Evaporation

Data Source

PatentUS10485841B2Method for producing dry extracts
Publication Date: 2019.11.26 BIONORICA AG
  • US10485841B2 patent drawing
  • US10485841B2 patent drawing
  • US10485841B2 patent drawing

AI summary

The invention relates to a method for producing dry extracts of plants and to pharmaceutical preparations containing the same, more particularly phytopharmaceuticals, which contain at least one ethanolic/aqueous extract of a plant (drug), the plants being selected from the group consisting of: Rumicis herba; Verbena officinalis; Sambucus nigra; Primula veris; and Gentiana lutea and mixtures thereof. The invention further relates to a pharmaceutical for treating inflammatory and/or infectious diseases of the nose and throat area and/or the nasal sinuses, as well as the use thereof.